Arbutus Biopharma Corporation (LON: 0SGC)
London
· Delayed Price · Currency is GBP · Price in USD
3.209
-0.010 (-0.31%)
At close: Jan 22, 2025
Arbutus Biopharma Revenue
Arbutus Biopharma had revenue of $1.34M USD in the quarter ending September 30, 2024, a decrease of -71.25%. This brings the company's revenue in the last twelve months to $6.74M, down -69.69% year-over-year. In the year 2023, Arbutus Biopharma had annual revenue of $18.14M, down -53.51%.
Revenue (ttm)
$6.74M
Revenue Growth
-69.69%
P/S Ratio
n/a
Revenue / Employee
$92.36K
Employees
73
Market Cap
495.42M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 18.14M | -20.88M | -53.51% |
Dec 31, 2022 | 39.02M | 28.03M | 255.11% |
Dec 31, 2021 | 10.99M | 4.07M | 58.92% |
Dec 31, 2020 | 6.91M | 903.00K | 15.02% |
Dec 31, 2019 | 6.01M | 66.00K | 1.11% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Shell | 221.41B |
AstraZeneca | 38.20B |
HSBC Holdings | 43.25B |
Unilever | 51.12B |
Rio Tinto Group | 42.87B |
RELX PLC | 9.30B |
BP p.l.c. | 144.69B |
British American Tobacco p.l.c. | 26.18B |